BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 35405582)

  • 1. Health-Related Quality of Life Over 6 Months in Patients With Major Depressive Disorder Who Started Antidepressant Monotherapy.
    Noto S; Wake M; Mishiro I; Hammer-Helmich L; Ren H; Moriguchi Y; Fujikawa K; Fernandez J
    Value Health Reg Issues; 2022 Jul; 30():127-133. PubMed ID: 35405582
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of life in major depressive disorder: the role of pain and pain catastrophizing cognition.
    Chung KF; Tso KC; Yeung WF; Li WH
    Compr Psychiatry; 2012 May; 53(4):387-95. PubMed ID: 21684536
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Importance of remission and residual somatic symptoms in health-related quality of life among outpatients with major depressive disorder: a cross-sectional study.
    Woo JM; Jeon HJ; Noh E; Kim HJ; Lee SW; Lee KK; Kim SH; Hong JP
    Health Qual Life Outcomes; 2014 Dec; 12():188. PubMed ID: 25519704
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chinese patients with major depression: Do concomitant pain symptoms affect quality of life independently of severity of depression?
    Novick D; Montgomery W; Moneta MV; Peng X; Brugnoli R; Haro JM
    Int J Psychiatry Clin Pract; 2015; 19(3):174-81. PubMed ID: 25946899
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of life and functioning of Hispanic patients with Major Depressive Disorder before and after treatment.
    López E; Steiner AJ; Manier K; Shapiro BB; Vanle B; Parisi T; Dang J; Chang T; Ganjian S; Mirocha J; Danovitch I; IsHak WW
    J Affect Disord; 2018 Jan; 225():117-122. PubMed ID: 28826087
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Health-related quality of life in amyotrophic lateral sclerosis using EQ-5D-5L.
    Wei QQ; Hou Y; Chen Y; Ou R; Cao B; Zhang L; Yang T; Shang H
    Health Qual Life Outcomes; 2021 Jul; 19(1):181. PubMed ID: 34284776
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assessment of health-related quality of life and health status in patients with treatment-resistant depression treated with esketamine nasal spray plus an oral antidepressant.
    Jamieson C; Popova V; Daly E; Cooper K; Drevets WC; Rozjabek HM; Singh J
    Health Qual Life Outcomes; 2023 May; 21(1):40. PubMed ID: 37158911
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship of cognitive impairment with depressive symptoms and psychosocial function in patients with major depressive disorder: Cross-sectional analysis of baseline data from PERFORM-J.
    Sumiyoshi T; Watanabe K; Noto S; Sakamoto S; Moriguchi Y; Tan KHX; Hammer-Helmich L; Fernandez J
    J Affect Disord; 2019 Nov; 258():172-178. PubMed ID: 31426015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Major Depression Comorbid with Medical Conditions: Analysis of Quality of Life, Functioning, and Depressive Symptom Severity.
    IsHak WW; Steiner AJ; Klimowicz A; Kauzor K; Dang J; Vanle B; Elzahaby C; Reid M; Sumner L; Danovitch I
    Psychopharmacol Bull; 2018 Jan; 48(1):8-25. PubMed ID: 29382957
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of esketamine on patient-reported outcomes in major depressive disorder with active suicidal ideation and intent: a pooled analysis of two randomized phase 3 trials (ASPIRE I and ASPIRE II).
    Jamieson C; Canuso CM; Ionescu DF; Lane R; Qiu X; Rozjabek H; Molero P; Fu DJ
    Qual Life Res; 2023 Nov; 32(11):3053-3061. PubMed ID: 37439961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changes in Quality of Life after 3 months of Usual Care in a Large Sample of Patients with Noncancer Pain: The "QOOL: Quality of Life and Pain" Study.
    Velázquez Rivera I; García Escobar M; Moya Riera JJ; Del Saz de la Torre JM; Fenollosa Vázquez P; González Mesa JM; Casado A; Martín Fuentes M; de Andrés Ares J
    Pain Pract; 2015 Sep; 15(7):633-42. PubMed ID: 25244352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A descriptive analysis of quality of life using patient-reported measures in major depressive disorder in a naturalistic outpatient setting.
    Ishak WW; Balayan K; Bresee C; Greenberg JM; Fakhry H; Christensen S; Rapaport MH
    Qual Life Res; 2013 Apr; 22(3):585-96. PubMed ID: 22544416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relief of depression and pain improves daily functioning and quality of life in patients with major depressive disorder.
    Lin CH; Yen YC; Chen MC; Chen CC
    Prog Neuropsychopharmacol Biol Psychiatry; 2013 Dec; 47():93-8. PubMed ID: 23989033
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing health-related quality of life of patients with colorectal cancer using EQ-5D-5L: a cross-sectional study in Heilongjiang of China.
    Huang W; Yang J; Liu Y; Liu C; Zhang X; Fu W; Shi L; Liu G
    BMJ Open; 2018 Dec; 8(12):e022711. PubMed ID: 30530472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Manualised cognitive-behavioural therapy in treating depression in advanced cancer: the CanTalk RCT.
    Serfaty M; King M; Nazareth I; Moorey S; Aspden T; Tookman A; Mannix K; Gola A; Davis S; Wood J; Jones L
    Health Technol Assess; 2019 May; 23(19):1-106. PubMed ID: 31097078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association between painful physical symptoms and clinical outcomes in East Asian patients with major depressive disorder: a 3-month prospective observational study.
    Ang QQ; Wing YK; He Y; Sulaiman AH; Chiu NY; Shen YC; Wang G; Zhang C; Lee KH; Singh P; Granger RE; Raskin J; Dossenbach M
    Int J Clin Pract; 2009 Jul; 63(7):1041-9. PubMed ID: 19570122
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between baseline cognitive symptoms and the subsequent presenteeism and global function in patients with major depressive disorder.
    Watanabe K; Marumoto T; Ge H; Moriguchi Y; Fujikawa K; Fernandez JL
    J Psychiatr Res; 2022 Oct; 154():324-331. PubMed ID: 36027860
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship of Subjective Cognitive Impairment with Psychosocial Function and Relapse of Depressive Symptoms in Patients with Major Depressive Disorder: Analysis of Longitudinal Data from PERFORM-J.
    Sumiyoshi T; Watanabe K; Noto S; Sakamoto S; Moriguchi Y; Hammer-Helmich L; Fernandez J
    Neuropsychiatr Dis Treat; 2021; 17():945-955. PubMed ID: 33814911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term follow-up on health-related quality of life in major depressive disorder: a 2-year European cohort study.
    Saragoussi D; Christensen MC; Hammer-Helmich L; Rive B; Touya M; Haro JM
    Neuropsychiatr Dis Treat; 2018; 14():1339-1350. PubMed ID: 29872301
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quality of life in major depressive disorder before/after multiple steps of treatment and one-year follow-up.
    IsHak WW; Mirocha J; James D; Tobia G; Vilhauer J; Fakhry H; Pi S; Hanson E; Nashawati R; Peselow ED; Cohen RM
    Acta Psychiatr Scand; 2015 Jan; 131(1):51-60. PubMed ID: 24954156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.